Alison T Stopeck

  • 9615 Citations
  • 37 h-Index
1982 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1992 2017

Nsaid Effects on Clinical and Imaging Breast Biomarkers

Stopeck, A. T. & Thompson, P.

National Institutes of Health

7/1/124/30/17

Project: Research projectResearch Project

Aromatase Inhibitors
Sulindac
Breast
Biomarkers
Breast Neoplasms
Diffusion Magnetic Resonance Imaging
Biomarkers
Breast Neoplasms
Neoplasm Metastasis
Therapeutics

DIFFUSION MRI AND CHEMOTHERAPEUTIC RESPONSE

Stopeck, A. T.

National Institutes of Health

8/1/007/31/03

Project: Research projectExploratory/Developmental Grants

Diffusion Magnetic Resonance Imaging
docetaxel
Water
Drug Therapy
Therapeutics
Cholesterol
Cytokines
LDL Receptors
Liver
Atherosclerosis

Research Output 1982 2018

Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI

Ding, J., Stopeck, A. T., Gao, Y., Marron, M. T., Wertheim, B. C., Altbach, M. I., Galons, J. P., Roe, D. J., Wang, F., Maskarinec, G., Thomson, C. A., Thompson, P. A. & Huang, C., Jan 1 2018, (Accepted/In press) In : Journal of Magnetic Resonance Imaging.

Research output: Contribution to journalArticle

Ionizing Radiation
Fats
Water
Breast Density
Breast
4 Citations

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Thomson, C. A., Chow, H. H. S., Wertheim, B. C., Roe, D. J., Stopeck, A., Maskarinec, G., Altbach, M., Chalasani, P., Huang, C., Strom, M. B., Galons, J. P. & Thompson, P. A., May 30 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

Tamoxifen
Tumor Biomarkers
Randomized Controlled Trials
Placebos
Breast Neoplasms
29 Citations
Drug Dose Response Relationship
Neoplasm Invasiveness
Drug Administration Schedule
Antineoplastic Combined Chemotherapy Protocols
ErbB-2 Receptor

Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?

Stopeck, A. T., Jul 1 2017, In : Cancer. 123, 13, p. 2392-2394 3 p.

Research output: Contribution to journalEditorial

Osteoclasts
Breast Neoplasms
3 Citations

Response to letter to the Editors—Safety of long-term denosumab therapy

Stopeck, A. T. & Warner, D. J., Feb 1 2017, In : Supportive Care in Cancer. 25, 2, p. 353-355 3 p.

Research output: Contribution to journalLetter